NASDAQ · Healthcare · Biotechnology
NextCure, Inc.
NXTC
NextCure, Inc. CEO Michael S. Richman · Market cap $24.5M.
$6.78
+0.13 · +1.95%
52w hi $15.7452w lo $1.55
Off 52w high 72.0%
60
NOTABLE
Current InsiderScore
Corp · 90d
9
9 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
3
0 strong · 3 notable
Analyst consensus
Strong Buy
Avg PT $20.00
Section 01
Recent Form 4 filings
9 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jul 31 | ADAR1 Capital Management, LLC | Buy | 8,003 | $4.80 | +$38K | 35 | |
| Jul 31 | ADAR1 Capital Management, LLC | Buy | 25,000 | $4.98 | +$125K | 54 | |
| Jul 30 | ADAR1 Capital Management, LLC | Buy | 20,000 | $5.00 | +$100K | 37 | |
| Jul 30 | ADAR1 Capital Management, LLC | Buy | 25,000 | $4.81 | +$120K | 57 | |
| Jul 30 | ADAR1 Capital Management, LLC | Buy | 77,850 | $4.96 | +$386K | 60 | |
| Jul 30 | ADAR1 Capital Management, LLC | Buy | 100,000 | $4.90 | +$490K | 60 | |
| Jul 30 | ADAR1 Capital Management, LLC | Buy | 50,000 | $4.97 | +$249K | 60 | |
| Jul 28 | ADAR1 Capital Management, LLC | Buy | 6,400 | $4.95 | +$32K | 35 | |
| Jul 27 | ADAR1 Capital Management, LLC | Buy | 7,798 | $5.00 | +$39K | 35 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug